NCT04908839

Brief Summary

Inclusion (J0):

  • Audiometry (as part of the treatment, only for cases)
  • Clinical evaluation (within the framework of care, only for cases)
  • Passage of the French version of the SPOT-25 questionnaire Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame. Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 9, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 6, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2022

Completed
Last Updated

February 14, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

May 26, 2021

Last Update Submit

February 11, 2023

Conditions

Keywords

SPOT-25

Outcome Measures

Primary Outcomes (1)

  • Comparison of the total score of cases and controls for the French version of the SPOT-25 questionnaire

    The SPOT-25 questionnaire includes 25 items and can be divided into 4 subscores: hearing function (items 1-10), tinnitus (items 11-13), mental condition (items 14-19), and social restrictions (items 20-24). In addition, 1 item focuses on the general evaluation of the impact of otosclerosis on HRQOL (item 25). Each question needs to be rated on a six-point ordinal scale from 0 (i.e., no impact) to 5 (i.e., most severe impact), depending on the level of inconvenience or frequency of symptoms.

    1 DAY

Study Arms (3)

case: patient with otosclerosis

Diagnosis of otosclerosis with indication for primary stapedial surgery by the combination of arguments

Other: spot-25 questionnaire

case: otosclerosis patient with surgery

otosclerosis patient with surgery

Other: spot-25 questionnaire

controle: Absence of known otological pathology

Absence of known otological pathology

Other: spot-25 questionnaire

Interventions

spot-25 questionnaire

case: otosclerosis patient with surgerycase: patient with otosclerosiscontrole: Absence of known otological pathology

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with otosclerosis and person with a known Absence of otological pathology

You may qualify if:

  • Patient aged\> 18 years
  • Diagnosis of otosclerosis with indication for primary stapes surgery by the combination of the arguments:
  • Clinical: normal eardrum and audiometry revealing conductive or mixed hearing loss with audiometric Rinne of\> 15 dB and absence of stapedial reflex.
  • Radiological: otosclerotic foci on preoperative CT scan
  • Non-opposition to participating in the study
  • Good understanding of French
  • Affiliate or beneficiary of a health insurance plan
  • Person aged\> 18 years
  • Absence of known otological pathology
  • Without otological surgical history
  • Non-opposition to participating in the study
  • Good understanding of French

You may not qualify if:

  • Comorbidity that may interfere with the interpretation of results
  • History of stapes surgery
  • Person benefiting from a legal protection measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fondation Adolphe de Rothschild

Paris, 75019, France

Location

Amélie YAvchitz

Paris, Île-de-France Region, 75019, France

Location

MeSH Terms

Conditions

Otosclerosis

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2021

First Posted

June 1, 2021

Study Start

September 9, 2021

Primary Completion

April 6, 2022

Study Completion

April 6, 2022

Last Updated

February 14, 2023

Record last verified: 2023-02

Locations